Details
Stereochemistry | ACHIRAL |
Molecular Formula | C17H12ClN5O2 |
Molecular Weight | 353.762 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=NN=C2CN=C(C3=C(Cl)C=CC=C3)C4=C(C=CC(=C4)[N+]([O-])=O)N12
InChI
InChIKey=XJRGLCAWBRZUFC-UHFFFAOYSA-N
InChI=1S/C17H12ClN5O2/c1-10-20-21-16-9-19-17(12-4-2-3-5-14(12)18)13-8-11(23(24)25)6-7-15(13)22(10)16/h2-8H,9H2,1H3
Molecular Formula | C17H12ClN5O2 |
Molecular Weight | 353.762 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 10:24:34 GMT 2023
by
admin
on
Sat Dec 16 10:24:34 GMT 2023
|
Record UNII |
HJH52YYC1X
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-Clonazolam
Created by
admin on Sat Dec 16 10:24:34 GMT 2023 , Edited by admin on Sat Dec 16 10:24:34 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SUB179333
Created by
admin on Sat Dec 16 10:24:34 GMT 2023 , Edited by admin on Sat Dec 16 10:24:34 GMT 2023
|
PRIMARY | |||
|
33887-02-4
Created by
admin on Sat Dec 16 10:24:34 GMT 2023 , Edited by admin on Sat Dec 16 10:24:34 GMT 2023
|
PRIMARY | |||
|
HJH52YYC1X
Created by
admin on Sat Dec 16 10:24:34 GMT 2023 , Edited by admin on Sat Dec 16 10:24:34 GMT 2023
|
PRIMARY | |||
|
12317881
Created by
admin on Sat Dec 16 10:24:34 GMT 2023 , Edited by admin on Sat Dec 16 10:24:34 GMT 2023
|
PRIMARY | |||
|
CLONAZOLAM
Created by
admin on Sat Dec 16 10:24:34 GMT 2023 , Edited by admin on Sat Dec 16 10:24:34 GMT 2023
|
PRIMARY | Clonazolam (also known as clonitrazolam) is a benzodiazepine that has been sold online as a designer drug.Clonazolam is reputed to be highly potent, and concerns have been raised that clonazolam and flubromazolam in particular may pose comparatively higher risks than other designer benzodiazepines, due to their ability to produce strong sedation and amnesia at oral doses of as little as 0.5 mg. | ||
|
100000164746
Created by
admin on Sat Dec 16 10:24:34 GMT 2023 , Edited by admin on Sat Dec 16 10:24:34 GMT 2023
|
PRIMARY | |||
|
DB14716
Created by
admin on Sat Dec 16 10:24:34 GMT 2023 , Edited by admin on Sat Dec 16 10:24:34 GMT 2023
|
PRIMARY | |||
|
DTXSID30101416
Created by
admin on Sat Dec 16 10:24:34 GMT 2023 , Edited by admin on Sat Dec 16 10:24:34 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE ACTIVE -> PARENT |
MAJOR
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |